Regulation of an essential innate immune response by the p50 subunit of NF-κB

Journal of Clinical Investigation

Volumn 102, Issue 9, 1998, Pages 1645-1652

  Bohuslav, Jan ^a   Kravchenko, Vladimir V ^a   Parry, Graham C N ^a   Erlich, Jonathan H ^a   Gerondakis, Steve ^b   Mackman, Nigel ^a   Ulevitch, Richard J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Walter and Eliza Hall Inst of Med ^*  (Australia)

Author keywords

Lipopolysaccharide; Macrophages; Regulation of transcription; Sepsis; Tumor necrosis factor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN SUBUNIT; SALMONELLA ENDOTOXIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTROPHORETIC MOBILITY; GENE EXPRESSION REGULATION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROMOTER REGION; SALMONELLA MINNESOTA; SEPSIS; STAPHYLOCOCCUS AUREUS; TRANSCRIPTION REGULATION;

EID: 0032211810     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3877     Document Type: Article

References (32)

1. Glauser, M.P., G. Zanetti, J.-D. Baumgartner, and J. Cohen. 1991. Septic shock: pathogenesis. Lancet. 338:732-736.
2. Ulevitch, R.J., and P.S. Tobias. 1994. Recognition of endotoxin by cells leading to transmembrane signalling. Curr. Opin. Immunol. 6:125-130.
3. Beeson, P.B. 1947. Tolerance to bacterial pyrogen. J. Exp. Med. 86:29-34.
4. Virca, G.D., S.Y. Kim, K.B. Glaser, and R.J. Ulevitch. 1989. Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells. J. Biol. Chem. 264:21951-21956.
5. Mathison, J.C., G.D. Virca, N. Wolfson, P.S. Tobias, K. Glaser, and R.J. Ulevitch. 1990. Adaptation to bacterial lipopolysaccharide (LPS) controls LPS-induced tumor necrosis factor production in rabbit macrophages. J. Clin. Invest. 85:1108-1118.
6. Ziegler-Heitbrock, H.W.L., M. Blumenstein, E. Kafferlein, K. Kieper, I. Petersmann, S. Endres, W.A. Flegel, H. Northoff, G. Reithmuller, and J.G. Haas. 1992. In vitro desensitization to lipopolysaccharide suppresses tumor necrosis factor, interleukin-1 and interleukin-6 gene expression in a similar fashion. Immunology. 75:264-268.
7. Zhang, X., and D.C. Morrison. 1993. Lipopolysaccharide-induced selective priming effects on tumor necrosis factor and nitric oxide production in mouse peritoneal macrophages. J. Exp. Med. 177:511-516.
8. LaRue, K.E.A., and C.E. McCall. 1994. A labile transcriptional repressor modulates endotoxin tolerance. J. Exp. Med. 180:2269-2275.
9. Boyte, W.R., E.A. Meals, and B.K. English. 1996. Acquired hyporesponsiveness to bacterial lipopolysaccharide and interferon-gamma in RAW 264.7 macrophages. Shock. 6:218-222.
10. Zhang, X., and D.C. Morrison. 1993. Lipopolysaccharide structure-function relationship in activation versus reprogramming of mouse peritoneal macrophages. J. Leukoc. Biol. 54:444-450.
11. Ziegler-Heitbrock, H.W.L., A. Wedel, W. Schraut, M. Strobel, P. Wendelgass, T. Sternsdorf, P.A. Bauerle, J.G. Haas, and G. Riethmuller. 1994. Tolerance to lipopolysaccharide involves mobilization of nuclear factor κB with predominance of p50 homodimers. J. Biol. Chem. 269:17001-17004.
12. Kravchenko, V.V., S. Steinemann, L. Kline, L. Feng, and R.J. Ulevitch. 1996. Endotoxin tolerance is induced in Chinese hamster ovary cell lines expressing human CD14. Shock. 194-201.
13. Sha, W.C., H.-C. Liou, E.I. Toumanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell. 80:321-330.
14. Kontgen, F., R.J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlington, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965-1977.
15. Mathison, J.C., E. Wolfson, and R.J. Ulevitch. 1988. Participation of tumor necrosis in the mediation of gram-negative bacterial lipopolysaccharide-induced injury in rabbits. J. Clin. Invest. 81:1925-1937.
16. Han, J., G. Huez, and B. Beutler. 1991. Interactive effects of the tumor necrosis factor promoter and 3′-untranslated regions. J. Immunol. 146:1843-1848.
17. Chiao, P.J., S. Miyamoto, and I.M. Verma. 1994. Autoregulation of IκB activity. Proc. Natl. Acad. Sci. USA. 91:28-32.
18. Kravchenko, V.V., Z. Pan, J. Han, J.-M. Herbert, R.J. Ulevitch, and R.D. Ye. 1995. Platelet-activating factor induces NF-κB activation through a G protein-coupled pathway. J. Biol. Chem. 270:14928-14934.
19. Dignam, J.D., R.M. Lebovitz, and R.G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
20. Gerondakis, S., A. Strasser, D. Metcalf, G. Grigoriadis, J.-P.Y. Scheerlink, and R.J. Grumont. 1996. Rel deficient T cells exhibit defects in the production of interleukin-3 and granulocyte-macrophage colony stimulating factor. Proc. Natl Acad. Sci. USA. 93:3405-3409.
21. Grigoriadis, G., Y. Zhan, R.J. Grumont, D. Metcalf, E. Handman, C. Cheers, and S. Gerondakis. 1996. The Rel subunit of NF-κB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. EMBO J. 15:7099-7107.
22. Shakhov, A.N., M.A. Collart, P. Vassalli, S.A. Nedospasov, and C.V. Jongeneel. 1990. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor gene in primary macrophages. J. Exp. Med. 171:35-47.
23. Collart, M.A., P. Baeuerle, and P. Vassalli. 1990. Regulation of tumor necrosis factor-transcription in macrophages: Involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol. Cell. Biol. 10:1498-1506.
24. Drouet, C., A.N. Shakhov, and C.V. Jongeneel. 1991. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-α promoter in primary macrophages. J. Immunol. 147:1694-1700.
25. Lienhard Schmitz, M., and P.A. Baeuerle. 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 10:3805-3817.
26. Franzoso, G., V. Bours, S. Park, M. Tomita-Yamaguchi, K. Kelly, and U. Siebenlist. 1992. The candidate oncoprotein Bcl-3 is an antagonist of p50/ NF-κB-mediated inhibition. Nature. 359:339-342.
27. Urban, M.B., R. Schreck, and P.A. Baeuerle. 1991. NF-κB contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO J. 10:1817-1825.
28. Kunsch, C., S.M. Ruben, and C.A. Rosen. 1992. Selection of optimal κB/Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol. Cell. Biol. 12:4412-4421.
29. Parry, G.C.N., and N. Mackman. 1994. A set of inducible genes expressed by activated human monocytic and endothelial cells contain κB-like sites that specifically bind c-Rel-p65 heterodimers. J. Biol. Chem. 269:20823-20825.
30. Urban, M.B., and P.A. Baeuerle. 1990. The 65-kD subunit of NF-κB is a receptor for IκB and a modulator of DNA-binding specifity. Genes Dev. 4: 1975-1984.
31. Loms-Ziegler-Heitbrock, H.W., and M. Frankenberger. 1998. LPS tolerance in monocytes/macrophages: three 3′ cytosins are required in the DNA binding motif for detection of upregulated NF-κB p50 homodimers. Immunobiologv. 198:81-90.
32. Cordle, S.R., R. Donald, M.A. Read, and J. Hawiger. 1993. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-κB proteins in human monocytic THP-1 cells. J. Biol. Chem. 268:11803-11810.